BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Deals

  QLT Inc. (JOBS) Announces Sale of QLT USA, Inc. to TOLMAR Inc. for up to $230 Million

  October 2, 2009

   · 

  6 min read
• Drug Development

  Intercept Pharmaceuticals’ FXR Agonist INT-747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease

  October 2, 2009

   · 

  2 min read
• Drug Development

  MannKind Corporation: AFRESA(R) Phase 3 Data Show Sustained Glycemic Control, Normal Lung Function in Patients over Four Years of Treatment

  October 2, 2009

   · 

  1 min read
• FDA

  ETEX Corporation Announces Additional FDA Clearance For EquivaBone(R), The First Hard Setting Osteoconductive and Osteoinductive Bone Graft Substitute

  October 2, 2009

   · 

  1 min read
• Pharm Country

  Novartis AG Pathfinding Drug Gleevec(R) Awarded Prestigious Prix Galien USA Award For Best Pharmaceutical Product

  October 2, 2009

   · 

  7 min read
• BioMidwest

  Military Approves H1N1 Testing with Idaho Technology Inc. JBAIDS

  October 2, 2009

   · 

  1 min read
• Business

  Sigma-Aldrich Corporation Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary

  October 2, 2009

   · 

  2 min read
• Drug Development

  Oncolytics Biotech Inc. Moving Reolysin into Late-Stage Study

  October 2, 2009

   · 

  6 min read
• Policy

  EU Agency Recommends Baxter International, Inc.'s (JOBS) H1N1 Flu Shot

  October 2, 2009

   · 

  5 min read
• Bundling Heart Meds Lowers Rates of MI and Stroke

  October 2, 2009

   · 

  1 min read